LL-37 (15-32)[Q8K,D12K,N16K]

General Information


DRACP ID  DRACP03679

Peptide Name   LL-37 (15-32)[Q8K,D12K,N16K]

Sequence  KEFKRIVKRIKKFLRKLV

Sequence Length  18

UniProt ID  P49913 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C111H197N33O21

Absent amino acids  ACDGHMNPQSTWY

Common amino acids  K

Mass  263339

Pl  12.31

Basic residues  9

Acidic residues  1

Hydrophobic residues  8

Net charge  8

Boman Index  -5115

Hydrophobicity  -54.44

Aliphatic Index  118.89

Half Life 
  Mammalian: 1.3 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  0

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 23689720

Title  Cationic antimicrobial peptides and biogenic silver nanoparticles kill mycobacteria without eliciting DNA damage and cytotoxicity in mouse macrophages

Doi Not available

Year  2013

Literature 2

Pubmed ID 21790937

Title  Cathelicidin is involved in the intracellular killing of mycobacteria in macrophages

Doi Not available

Year  2011

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  11036

DRACP is developed by Dr.Zheng's team.